Article
Mechanism for the homocysteine-enhanced antifibrinolytic potential of lipoprotein(a) in human plasma.
Thrombosis and haemostasis - 1 Jul 2005
Nardulli Marina, Durlach Vincent, Pepe Gabriella, Anglés-Cano Eduardo
Abstract excerpt
Lipoprotein(a) and total plasma homocysteine levels are now established as independent atherothrombogenic risk factors. A distinctive pathophysiological feature of lipoprotein(a) is its antifibrinolytic activity, an effect dependent on plasma concentration and high affinity for fibrin of its small size apo(a) component. A stimulating effect of homocysteine on purified lipoprotein(a) has been proposed. However,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
